COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2.

scientific article

COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...856211L
P356DOI10.1371/JOURNAL.PONE.0056211
P932PMC publication ID3570459
P698PubMed publication ID23424651
P5875ResearchGate publication ID235670899

P50authorMin-Chuan HuangQ56971865
Ji-Shiang HungQ59697431
P2093author name stringJohn Huang
Chia-Hua Chen
Miao-Juei Huang
Ming-Ting Chen
Ya-Hsin Chen
Jian Lee
P2860cites workHistopathology of Vascular AnomaliesQ56567233
Cloning and expression of human core 1 beta1,3-galactosyltransferaseQ24291836
Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in miceQ24652041
The splice variants of vascular endothelial growth factor (VEGF) and their receptorsQ28200155
Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangiomaQ28216461
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibitionQ28238040
Cosmc is an essential chaperone for correct protein O-glycosylationQ28506209
Hemangiomas in childrenQ30732724
The sweet and sour of cancer: glycans as novel therapeutic targetsQ34439560
The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progressionQ34622638
Cancer vaccines and carbohydrate epitopesQ35525289
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.Q35747092
Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomasQ35764279
Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone CosmcQ36817899
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangiomaQ36995485
Mucin-type O-glycosylation and its potential use in drug and vaccine developmentQ36995685
Recent insights into the biological roles of mucin-type O-glycosylationQ37130137
Infantile hemangiomas: how common are they? A systematic review of the medical literatureQ37145076
Carbohydrate vaccines: developing sweet solutions to sticky situations?Q37426039
The Tn antigen-structural simplicity and biological complexityQ37831859
Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptorQ39459644
Targeted disruption of the gene encoding core 1 beta1-3-galactosyltransferase (T-synthase) causes embryonic lethality and defective angiogenesis in miceQ48365705
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageQuantQ112270642
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectendotheliumQ111140
cell growthQ189159
infantile hemangiomaQ52771370
overexpressionQ61643320
P304page(s)e56211
P577publication date2013-02-12
P1433published inPLOS OneQ564954
P1476titleCOSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2.
P478volume8

Reverse relations

cites work (P2860)
Q34867993Biology of infantile hemangioma
Q47983641Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis
Q37727574Identification of a novel protein binding motif within the T-synthase for the molecular chaperone Cosmc
Q39327604Infantile Periocular Hemangioma
Q38667341Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells
Q26996608Signaling pathways in the development of infantile hemangioma
Q38966611Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen